Infections: all 6,701 studies

Page 27 of 68. Open to participants first (800), then studies with results posted, then the rest; newest registration first within each.

• Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 DiabetesCompletedNCT05171998
• Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)TerminatedNCT05170269Phase 3
• Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.CompletedNCT05169255Phase 3
• Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection ReductionCompletedNCT05168709Phase 4
• Optimisation of Antibiotic Prescription in Acute Noncomplicated Respiratory Tract Infections in Children (OptimAP Study)CompletedNCT05166369Not applicable
• Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in ChildrenCompletedNCT05164692Not applicable
• CovidSurg-3: Outcomes of Surgery in COVID-19 InfectionStatus unknownNCT05161299
• Effect of Covid 19 Infection on Fetomaternal OutcomeStatus unknownNCT05160649
• Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.CompletedNCT05156723Phase 1/2
• Comprehensive Diagnosis and Treatment Strategy for Opportunistic Fungal Infections in AIDS PatientsStatus unknownNCT05153005
• Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 InfectionCompletedNCT05152849Phase 2
• Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant PatientsCompletedNCT05150327
• mNGS Versus Blood Culture in FNStatus unknownNCT05149547
• A Study of Acute Respiratory Infections in Global Outpatient SettingCompletedNCT05148780Early Phase 1
• EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.Active, not recruitingNCT05148702Phase 3
• Residual Symptoms and the Quality of Life in Individuals Recovered From COVID-19 Infection: A Survey From PakistanCompletedNCT05148676
• Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant SettingStatus unknownNCT05145803
• Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 InfectionCompletedNCT05143320
• Chlorhexidine Bathing to Prevent Hospital-acquired Infections: the CLEANS StudyStatus unknownNCT05142969Not applicable
• A Blood Test to Diagnose Sepsis in Symptomatic Adults and ChildrenStatus unknownNCT05142813
• Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to HospitalCompletedNCT05142748
• Extended Spectrum Beta Lactamase Producing Organisms In Urinary Tract InfectionsStatus unknownNCT05141188
• CMV-TCR-T Cells for CMV Infection After Allogenic HSCTStatus unknownNCT05140187Phase 1
• Peripheral Venous Catheter Related Blood Stream InfectionsStatus unknownNCT05139628
• Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)CompletedNCT05137314Phase 1
• VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIACompletedNCT05135455
• Retrospective Evaluation of Clinical, Virological and Serological Data in Patients With Mild Acute Upper Respiratory Tract InfectionsCompletedNCT05134766
• Antibiotic Concentration After Delivery to Middle Ear for Chronic Suppurative Otitis MediaCompletedNCT05133258
• Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori InfectionStatus unknownNCT05133193Not applicable
• Infection Prevention and Control Practices Regarding COVID-19CompletedNCT05130749
• Pharmacokinetics of Fluconazole in Children (2-18 Years)Status unknownNCT05130723
• A Study of Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)WithdrawnNCT05130086Phase 2
• Partially Hydrolyzed Guar Gum (PHGG) for Amelioration of Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT05126654Not applicable
• Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori InfectionStatus unknownNCT05126121Not applicable
• Validation of HyperDetector for SARS-CoV-2SuspendedNCT05124496
• Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 InfectionActive, not recruitingNCT05122754Phase 4
• Is the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice?CompletedNCT05117671
• Streptococcus Pyogenes Carriage Acquisition and Transmission StudyCompletedNCT05117528
• SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort StudyStatus unknownNCT05116956
• Infection Control Program in Tracheostomized PatientsStatus unknownNCT05113329
• Osteopathic Manipulative Therapy Effects on Prolonged Post-COVID Olfactory DysfunctionCompletedNCT05112887Not applicable
• Probiotics Role in HPV Cervico-vaginal Infection ClearanceCompletedNCT05109533Not applicable
• Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients.CompletedNCT05109455Phase 4
• Risk Stratification Using Midregional Proadrenomedullin in the EDCompletedNCT05108883Not applicable
• Microbiome and Malnutrition in Pregnancy (MMiP)Active, not recruitingNCT05108675
• Clinical Performance of the Checkable Medical At-Home Strep A TestCompletedNCT05107362
• Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern JordanCompletedNCT05106803
• Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency RoomTerminatedNCT05105191Not applicable
• A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647CompletedNCT05105048Phase 1
• Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health SciencesCompletedNCT05104385
• Tauropace to Prevent Cardiac Implantable Device Infections in Heart Failure PatientsStatus unknownNCT05103267
• Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori InfectionStatus unknownNCT05100446Early Phase 1
• Establishment of Risk Indicators and Early Warning System in Infection PatientsStatus unknownNCT05099120
• PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19Status unknownNCT05096052Phase 3
• Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).CompletedNCT05094687
• E-Health for Zero Infections - Facilitating Access to and Use of HIV Pre-Exposure Prophylaxis (PrEP) in the NetherlandsCompletedNCT05093036Not applicable
• Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus InfectionStatus unknownNCT05092074
• Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical ProceduresCompletedNCT05090657Phase 2
• Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health CareCompletedNCT05090475Not applicable
• Micro-hematology Analyzer for Viral/Bacterial DescriptionStatus unknownNCT05090319
• Title: Povidone-soaked Sutures Versus Ordinary Sutures for Reducing Surgical Site InfectionStatus unknownNCT05090176Not applicable
• CMV-TCR-T Cells for Refractory CMV Infection After HSCTStatus unknownNCT05089838Phase 1
• A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy VolunteersCompletedNCT05088421Phase 1
• Infections in Migrants in Sweden - the Importance of Malaria and Other Parasitic InfectionsStatus unknownNCT05086887
• Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)WithdrawnNCT05085574Phase 2
• Cardiovascular Disease and Outcomes Among Patients With SARS-CoV-2 Infection (COVID-19)Status unknownNCT05085262
• VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19TerminatedNCT05084755
• Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19CompletedNCT05083039
• Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill PatientsStatus unknownNCT05082168
• Rosmalip® for Cancer Infections PreventionCompletedNCT05080920Not applicable
• Collection and Distribution of Biospecimens for Novel ResearchStatus unknownNCT05080907
• Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site InfectionsStatus unknownNCT05077592Phase 4
• Bezlotoxumab Versus FMT for Multiple Recurrent CDIWithdrawnNCT05077085Phase 4
• Efficacy of Ivermectin in COVID-19CompletedNCT05076253Phase 1/2
• Musculoskeletal Problems and Endurance in Healthcare Professionals With and Without COVID-19Status unknownNCT05075018
• Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)CompletedNCT05074719
• Severity of RSV Infections in TwinsCompletedNCT05070975
• Effect of an Enzyme-containing Lozenge on Dental Biofilm in Healthy Individuals.CompletedNCT05070507Not applicable
• A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult VolunteersCompletedNCT05069623Phase 1/2
• COVID-19 Infection in Hemodialysis PatientsStatus unknownNCT05069532
• SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV CohortCompletedNCT05067400
• Lung Ultrasound Findings in Patients With COVID-19 in a UK EDCompletedNCT05065827
• TTV Viral Load in Heart Transplant RecipientsCompletedNCT05064462
• Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19CompletedNCT05063812
• NOWDx Test for the Diagnosis of SyphilisCompletedNCT05063344
• Lung Ultrasound Changes in Covid 19 Patients Discharged From HospitalCompletedNCT05062603
• Abdominal Wall Reconstruction With PVDF Mesh in the Setting of Active InfectionCompletedNCT05061264Not applicable
• Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract InfectionsStatus unknownNCT05060419Phase 2
• A One Health Study of Monkeypox Human InfectionActive, not recruitingNCT05058898
• COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS)CompletedNCT05055466
• Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19Status unknownNCT05054075Phase 2
• Prophylactic Negative Pressure Wound Therapy for Patients Undergoing Incisional Hernia RepairStatus unknownNCT05050786Not applicable
• Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 VaccineCompletedNCT05049226Phase 2
• Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19CompletedNCT05049213Phase 4
• COVID-Like Illness Respiratory Pathogens. A Prospective Cohort on the COVID-19 Post-acute ConditionStatus unknownNCT05047666
• Bacillus Clausii in Liver TransplantationActive, not recruitingNCT05047406Phase 2
• Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case SeriesCompletedNCT05046652
• Development of an Artificial Intelligence System for Intelligent Pathological Diagnosis and Therapeutic Effect Prediction Based on Multimodal Data Fusion of Common Tumors and Major Infectious Diseases in the Respiratory System Using Deep Learning Technology.Status unknownNCT05046366
• Prediction of Patient Deterioration Using Machine LearningCompletedNCT05045742
• Safety and Immune Response of COVID-19 Vaccination in Patients With HIV InfectionStatus unknownNCT05043129

← Infections overview